Part D formulary changes
Executive Summary
CMS will accept negative formulary change requests from Medicare Part D plan sponsors for the 2007 benefit year until July 31, but the agency can only guarantee that what are considered to be "maintenance" change requests will be reviewed, according to a June 20 1memo to sponsors. Maintenance revisions might include moving a brand name product to a less preferred tier after a generic version is approved or changes for safety reasons. The agency also will allow sponsors to request certain types of changes from Aug. 8-10 in the Part D formularies that have already been submitted for 2008. "Allowable" changes specified in the memo include deletion of a drug along with the corresponding addition of a drug within the same USP class at the same, or lower, beneficiary cost-sharing level...
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.